Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants
Clinical trial NCT03281577 · COMPLETED
Trial details
- NCT number
- NCT03281577
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-02
- Primary completion
- 2019-06-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.